Rick R. Suárez

Senior Vice President, US President and Head of US BioPharmaceuticals Business Unit

Responsibilities

Rick R. Suárez is the Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. In this role, Suárez is responsible for the execution of AstraZeneca’s $50 billion US research, development and manufacturing investment, including construction of a $4.5 billion manufacturing facility in Virginia, the Company’s largest single manufacturing investment globally. He also leads AstraZeneca’s US BioPharmaceuticals organization, with accountability for performance, growth and execution across the portfolio, including the Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology therapy areas. 

Prior Experience

Previously, Suárez served as the President of AstraZeneca Spain (2020-2025), where he led one of AstraZeneca’s strongest performing European markets. He managed a period of remarkable transformation, driving substantial sales growth and expanding the workforce from 800 to more than 3,000 employees. During his tenure in Spain, Suárez established a new global hub in Barcelona and launched the AstraZeneca Healthcare Innovation Hub, committing more than $10 million to digital health and data-driven initiatives focused on translational innovation. 

With more than 25 years of experience at AstraZeneca, Suárez has also held senior roles in sales, marketing, medical affairs, market access and government relations. Prior to his role in Spain, he served as Senior Vice President of US Market Access, where he led initiatives to improve patient access to therapies and support health system sustainability. 

Education

• Bachelor of Art, University of North Alabama, Florence, AL